308 related articles for article (PubMed ID: 16140963)
21. Increased expression of type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) and its relationship with androgen receptor in prostate carcinoma.
Fung KM; Samara EN; Wong C; Metwalli A; Krlin R; Bane B; Liu CZ; Yang JT; Pitha JV; Culkin DJ; Kropp BP; Penning TM; Lin HK
Endocr Relat Cancer; 2006 Mar; 13(1):169-80. PubMed ID: 16601286
[TBL] [Abstract][Full Text] [Related]
22. 15-Hydroxyprostaglandin dehydrogenase (15-PGDH) is up-regulated by flurbiprofen and other non-steroidal anti-inflammatory drugs in human colon cancer HT29 cells.
Chi X; Freeman BM; Tong M; Zhao Y; Tai HH
Arch Biochem Biophys; 2009 Jul; 487(2):139-45. PubMed ID: 19501039
[TBL] [Abstract][Full Text] [Related]
23. Amyloid precursor protein is a primary androgen target gene that promotes prostate cancer growth.
Takayama K; Tsutsumi S; Suzuki T; Horie-Inoue K; Ikeda K; Kaneshiro K; Fujimura T; Kumagai J; Urano T; Sakaki Y; Shirahige K; Sasano H; Takahashi S; Kitamura T; Ouchi Y; Aburatani H; Inoue S
Cancer Res; 2009 Jan; 69(1):137-42. PubMed ID: 19117996
[TBL] [Abstract][Full Text] [Related]
24. Vasoactive intestinal peptide induces cyclooxygenase-2 expression through nuclear factor-kappaB in human prostate cell lines Differential time-dependent responses in cancer progression.
Fernández-Martínez AB; Collado B; Bajo AM; Sánchez-Chapado M; Prieto JC; Carmena MJ
Mol Cell Endocrinol; 2007 May; 270(1-2):8-16. PubMed ID: 17434257
[TBL] [Abstract][Full Text] [Related]
25. Anticancer effects of licofelone (ML-3000) in prostate cancer cells.
Narayanan NK; Nargi D; Attur M; Abramson SB; Narayanan BA
Anticancer Res; 2007; 27(4B):2393-402. PubMed ID: 17695530
[TBL] [Abstract][Full Text] [Related]
26. The aryl propionic acid R-flurbiprofen selectively induces p75NTR-dependent decreased survival of prostate tumor cells.
Quann EJ; Khwaja F; Zavitz KH; Djakiew D
Cancer Res; 2007 Apr; 67(7):3254-62. PubMed ID: 17409433
[TBL] [Abstract][Full Text] [Related]
27. Expression of biomarkers modulating prostate cancer angiogenesis: differential expression of annexin II in prostate carcinomas from India and USA.
Banerjee AG; Liu J; Yuan Y; Gopalakrishnan VK; Johansson SL; Dinda AK; Gupta NP; Trevino L; Vishwanatha JK
Mol Cancer; 2003 Oct; 2():34. PubMed ID: 14613585
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms for the prevention of gastrointestinal cancer: the role of prostaglandin E2.
Backlund MG; Mann JR; Dubois RN
Oncology; 2005; 69 Suppl 1():28-32. PubMed ID: 16210874
[TBL] [Abstract][Full Text] [Related]
29. Increased expression of interleukin-1alpha and cyclooxygenase-2 in human gastric cancer: a possible role in tumor progression.
Uefuji K; Ichikura T; Mochizuki H
Anticancer Res; 2005; 25(5):3225-30. PubMed ID: 16101131
[TBL] [Abstract][Full Text] [Related]
30. Regulation of prostaglandin availability in human fetal lung by differential localisation of prostaglandin H synthase-1 and prostaglandin dehydrogenase.
Conner CE; Kelly RW; Hume R
Histochem Cell Biol; 2001 Oct; 116(4):313-9. PubMed ID: 11702189
[TBL] [Abstract][Full Text] [Related]
31. Nonsteroidal anti-inflammatory drugs for treatment of advanced gastric cancer: cyclooxygenase-2 is involved in hepatocyte growth factor mediated tumor development and progression.
Chen JH; Liu TY; Wu CW; Chi CW
Med Hypotheses; 2001 Oct; 57(4):503-5. PubMed ID: 11601879
[TBL] [Abstract][Full Text] [Related]
32. 15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer.
Wolf I; O'Kelly J; Rubinek T; Tong M; Nguyen A; Lin BT; Tai HH; Karlan BY; Koeffler HP
Cancer Res; 2006 Aug; 66(15):7818-23. PubMed ID: 16885386
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of cyclooxygenase-2 activity by celecoxib does not lead to radiosensitization of human prostate cancer cells in vitro.
Ohneseit PA; Krebiehl G; Dittmann K; Kehlbach R; Rodemann HP
Radiother Oncol; 2007 Feb; 82(2):229-38. PubMed ID: 17207548
[TBL] [Abstract][Full Text] [Related]
34. [Transcriptional regulation of placental transforming growth factor-beta by calcitriol in prostate cancer cells is androgen-independent].
Nazarova NIu; Chikhirzhina GI; Tuohimaaa P
Mol Biol (Mosk); 2006; 40(1):84-9. PubMed ID: 16523695
[TBL] [Abstract][Full Text] [Related]
35. Regulation of growth hormone receptors in human prostate cancer cell lines.
Bidosee M; Karry R; Weiss-Messer E; Barkey RJ
Mol Cell Endocrinol; 2009 Oct; 309(1-2):82-92. PubMed ID: 19540305
[TBL] [Abstract][Full Text] [Related]
36. Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer.
Stanbrough M; Bubley GJ; Ross K; Golub TR; Rubin MA; Penning TM; Febbo PG; Balk SP
Cancer Res; 2006 Mar; 66(5):2815-25. PubMed ID: 16510604
[TBL] [Abstract][Full Text] [Related]
37. Androgen deprivation increases p300 expression in prostate cancer cells.
Heemers HV; Sebo TJ; Debes JD; Regan KM; Raclaw KA; Murphy LM; Hobisch A; Culig Z; Tindall DJ
Cancer Res; 2007 Apr; 67(7):3422-30. PubMed ID: 17409453
[TBL] [Abstract][Full Text] [Related]
38. Effects of simvastatin, acetylsalicylic acid, and rosiglitazone on proliferation of normal and cancerous prostate epithelial cells at therapeutic concentrations.
Murtola TJ; Pennanen P; Syvälä H; Bläuer M; Ylikomi T; Tammela TL
Prostate; 2009 Jun; 69(9):1017-23. PubMed ID: 19301305
[TBL] [Abstract][Full Text] [Related]
39. Vasoactive intestinal peptide behaves as a pro-metastatic factor in human prostate cancer cells.
Fernández-Martínez AB; Bajo AM; Sánchez-Chapado M; Prieto JC; Carmena MJ
Prostate; 2009 May; 69(7):774-86. PubMed ID: 19189304
[TBL] [Abstract][Full Text] [Related]
40. Adenocarcina of the mouse prostate growth inhibition by celecoxib: downregulation of transcription factors involved in COX-2 inhibition.
Narayanan BA; Narayanan NK; Pttman B; Reddy BS
Prostate; 2006 Feb; 66(3):257-65. PubMed ID: 16175586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]